Bausch Health (formerly Valeant Pharmaceuticals International) is Canada's largest publicly traded drugmaker. The multinational specialty pharmaceutical company specializes in developing, manufacturing, and marketing pharmaceuticals and medical devices, with a portfolio of branded prescription, branded generic, and OTC products. Its core specialty areas are eye care (largely due to the work of its Bausch + Lomb subsidiary), gastroenterology, and dermatology. Subsidiary Salix Pharmaceuticals makes such gastrointestinal medications as Xifaxan, Relistor, and Lucemyra. Products in Bausch Health's dermatology segment include genital herpes treatment Zovirax and acne treatment Acanya.
See detailed business credit reports on other businesses or your own.
See detailed profiles for insights and prospects on this company's top competitors.
Essential information for a successful call
EMPLOYEES (This Site)
EMPLOYEES (All Sites)
- ASSETS (MIL USD) 33863.0
REVENUE (MIL USD)
- TICKER SYMBOL BHC
- Incorporated 1994
- FISCAL YEAR END DEC
- SALES GROWTH % 2.64%
Get in Touch with 19 Principals*
Joseph C. PapaChairman of the Board and Member of the Board of Directors
Paul S. HerendeenExecutive Vice President and Chief Financial Officer
Christina M. AchkermannExecutive Vice President
Thomas J. AppioVice President